Shenglan Wang

Dr. Shenglan Wang

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2021 in Life
Verified
Journal Article
Open access
PDF file
SWShenglan Wang
Shenglan Wang
YDYi Dai
Yi Dai
Pain is an unpleasant sensory and emotional state that decreases quality of life. A metabolic sensor, adenosine monophosphate-activated protein kinase (AMPK), which is ubiquitously expressed in mammalian cells, has recently attracted interest as a new target of pain research. Abnormal AMPK expression and function in the peripheral and central nervous systems are associated with various types of pain. AMPK and its downstream kinases participate in the regulation of neuron excitability, neuroinflammation and axonal and myelin regeneration. Numerous AMPK activators have reduced pain behavior in animal models. The current understanding of pain has been deepened by AMPK research, but certain issues, such as the interactions of AMPK at each step of pain regulation, await further investigation. This review examines the roles of AMPK and its downstream kinases in neurons and non-neuronal cells, as well as their contribution to pain regulation.

Verified
Journal Article
Open access
PDF file
HKHirosato Kanda
Hirosato Kanda
YYYanjing Yang
Yanjing Yang
SDShaoqi Duan
Shaoqi Duan
YKYoko Kogure
Yoko Kogure
SWShenglan Wang
Shenglan Wang
YDYi Dai
Yi Dai
Atractylodin (ATR) is a bioactive component found in dried rhizomes of Atractylodes lancea (AL) De Candolle. Although AL has accumulated empirical evidence for the treatment of pain, the molecular mechanism underlying the anti-pain effect of ATR remains unclear. In this study, we found that ATR increases transient receptor potential ankyrin-1 (TRPA1) single-channel activity in hTRPA1 expressing HEK293 cells. A bath application of ATR produced a long-lasting calcium response, and the response was completely diminished in the dorsal root ganglion neurons of TRPA1 knockout mice. Intraplantar injection of ATR evoked moderate and prolonged nociceptive behavior compared to the injection of allyl isothiocyanate (AITC). Systemic application of ATR inhibited AITC-induced nociceptive responses in a dose-dependent manner. Co-application of ATR and QX-314 increased the noxious heat threshold compared with AITC in vivo. Collectively, we concluded that ATR is a unique agonist of TRPA1 channels, which produces long-lasting channel activation. Our results indicated ATR-mediated anti-nociceptive effect through the desensitization of TRPA1-expressing nociceptors.

Verified
Journal Article
Open access
PDF file
HCHerong Cui
Herong Cui
WGWenbo Guo
Wenbo Guo
BZBeibei Zhang
Beibei Zhang
GLGuoping Li
Guoping Li
TLTong Li
Tong Li
PWPenglong Wang
Penglong Wang
There is a need for an efficient and low-cost leading compound discovery mode. However, drug development remains slow, expensive, and risky. Here, this manuscript proposes a leading compound discovery strategy based on a combination of traditional Chinese medicine (TCM) formulae and pharmacochemistry, using a ligustrazine–betulinic acid derivative (BA-12) in the treatment of angiogenesis as an example. Blocking angiogenesis to inhibit the growth and metastasis of solid tumors is currently one recognized therapy for cancer in the clinic. Firstly, based on a traditional Prunella vulgaris plaster, BA-12 was synthesized according to our previous study, as it exhibited better antitumor activities than other derivatives on human bladder carcinoma cells (T24); it was then uploaded for target prediction. Secondly, the efficacy and biotoxicity of BA-12 on angiogenesis were evaluated using human umbilical vein endothelial cells (HUVECs), a quail chick chorioallantoic membrane, and Caenorhabditis elegans. According to the prediction results, the main mechanisms of BA-12 were metabolic pathways. Thus, multiple metabolomics approaches were applied to reveal the mechanisms of BA-12. Finally, the predictive mechanisms of BA-12 on glutathione metabolism and glycerophospholipid metabolism activation were validated using targeted metabolomics and pharmacological assays. This strategy may provide a reference for highly efficient drug discovery, with the aim of sharing TCM wisdom for unmet clinical needs.

25 November 2020 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
SWShenglan Wang
Shenglan Wang
SQSimin Qi
Simin Qi
YKYoko Kogure
Yoko Kogure
HKHirosato Kanda
Hirosato Kanda
LTLin Tian
Lin Tian
YDYi Dai
Yi Dai

Verified
Journal Article
Open access
PDF file
HCHerong Cui
Herong Cui
WGWenbo Guo
Wenbo Guo
BZBeibei Zhang
Beibei Zhang
GLGuoping Li
Guoping Li
TLTong Li
Tong Li
PWPenglong Wang
Penglong Wang
The authors wish to make the following corrections to this paper

10 December 2022 in The Anatomical Record
Verified
Journal Article
Closed access
XWXinting Wang
Xinting Wang
JWJihong Wu
Jihong Wu
RHRui Huang
Rui Huang
SWShenglan Wang
Shenglan Wang